Search Results - BC Cancer Agency Library

Development and application of an in vitro culture model for primary human T-all cells

https://bccalibrary.andornot.com/en/permalink/catalog21286

Yost, Arla June. [Vancouver, BC?]: University of British Columbia , 2012.

Audience: Professional

Call Number: LE3 2012 Y65

Availability: 1 copy, 1 available

Author: Yost, Arla June

Place of Publication: [Vancouver, BC?]

Publisher: University of British Columbia

Publication Date: 2012

Subjects: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Models, Biological; Cell Culture Techniques

Language: English

Material Type: Book; Thesis

Audience: Professional

Location: Vancouver Library

Call Number: LE3 2012 Y65

Copies

c.1 BC Cancer Agency VAN Library

Available

Identification of differentially expressed genes in AHI-1-mediated leukemic transformation in cutaneous T-cell lymphoma

https://bccalibrary.andornot.com/en/permalink/catalog17855

Kennah, Erin. [Vancouver, BC?]: University of British Columbia , 2008.

Audience: Professional

Call Number: LE3 2008 K34

Availability: 1 copy, 1 available

Author: Kennah, Erin

Place of Publication: [Vancouver, BC?]

Publisher: University of British Columbia

Publication Date: 2008

Physical Description: x, 92 p. : ill. ; 28 cm.

Subjects: Lymphoma, T-Cell, Cutaneous - genetics; AHI1 protein, human

Language: English

Material Type: Book; Thesis

Audience: Professional

Location: Vancouver Library

Call Number: LE3 2008 K34

Copies

c.1 BC Cancer Agency VAN Library

Available

Chimeric antigen receptor t-cell therapies for cancer : a practical guide

https://bccalibrary.andornot.com/en/permalink/catalog122174

Cambridge, MA: Elsevier, Inc. , 2020.

Audience: Professional

Call Number: QZ266 C538 2020

Availability: 3 copies, 3 available

Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients r…

Editor: Lee, Daniel W.; Shah, Nirali N.

Place of Publication: Cambridge, MA

Publisher: Elsevier, Inc.

Publication Date: 2020

Physical Description: xiv, 229 p. : ill. ; 24 cm.

Subjects: Neoplasms - therapy; Receptors, Chimeric Antigen - therapeutic use; Receptors, Antigen, T-Cell; Immunotherapy, Adoptive - methods; Cell- and Tissue-Based Therapy

Abstract: Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.